Management of adverse events associated with tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia. [electronic resource]
Producer: 20110408Description: 201-10 p. digitalISSN:- 1476-5551
- Benzamides
- Dasatinib
- Disease Management
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- complications
- Piperazines -- adverse effects
- Protein Kinase Inhibitors -- adverse effects
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrimidines -- adverse effects
- Thiazoles -- adverse effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.